Zydus Cadila looking to supply COVID-19 vaccine ZyCoV-D by middle to end of September

Zydus Cadila is looking to supply its COVID-19 vaccine ZyCoV-D by the middle to end of September, and the pricing of the dose will be announced in the next one or two weeks. The company's indigenously developed needle-free three-dose COVID-19 vaccine ZyCoV-D was granted emergency use authorisation (EUA) by the drug regulator, making it the first vaccine to be administered to beneficiaries in the age group of 12-18 years in the country.

Cadila Healthcare is an India-based pharmaceutical company. The company's subsidiaries include Zydus Wellness, Liva Pharmaceuticals, Biochem Pharmaceutical Industries, Zydus Technologies, German Remedies, Dialforhealth India, Dialforhealth Unity and Dialforhealth Greencross, among others.